A Prospective Non-interventional/Observational Patient Cohort Study on the Efficacy of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms GENISIS
- 10 Jun 2017 Biomarkers information updated
- 10 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2010 Planned end date changed from 1 Aug 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov record.